Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-15-037320
Filing Date
2015-10-09
Accepted
2015-10-09 16:14:22
Documents
1
Period of Report
2015-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4120
  Complete submission text file 0001140361-15-037320.txt   5534
Mailing Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080
Business Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAZZ PHARMACEUTICALS PLC 4TH FL.CONNAUGHT HOUSE, 1 BURLINGTON RD. DUBLIN L2 4
Business Address
Young Matthew P. (Reporting) CIK: 0001601583 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 151153302